HK1097532A1 - Tricyclic delta opioid modulators - Google Patents

Tricyclic delta opioid modulators

Info

Publication number: HK1097532A1
Authority: HK; Hong Kong
Prior art keywords: delta opioid; opioid modulators; tricyclic; tricyclic delta; modulators
Prior art date: 2003-06-27

Application number

HK07103171.8A

Other languages

English (en)

Inventor

John R Carson

Ellen Codd

Christine M Razler

Andrea Works

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2007-03-23

Publication date

2007-06-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33563931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1097532(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-03-23 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2007-06-29 Publication of HK1097532A1 publication Critical patent/HK1097532A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Psychology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Transplantation (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HK07103171.8A 2003-06-27 2007-03-23 Tricyclic delta opioid modulators HK1097532A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48338903P	2003-06-27	2003-06-27
PCT/US2004/019911 WO2005003131A1 (en)	2003-06-27	2004-06-22	Tricyclic delta opioid modulators

Publications (1)

Publication Number	Publication Date
HK1097532A1 true HK1097532A1 (en)	2007-06-29

Family

ID=33563931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK07103171.8A HK1097532A1 (en)	2003-06-27	2007-03-23	Tricyclic delta opioid modulators

Country Status (20)

Country	Link
US (4)	US7589103B2 (es)
EP (1)	EP1644373A1 (es)
JP (1)	JP4810423B2 (es)
KR (1)	KR101132208B1 (es)
CN (1)	CN100513407C (es)
AR (1)	AR044940A1 (es)
AU (1)	AU2004253898A1 (es)
BR (1)	BRPI0411998A (es)
CA (1)	CA2530444C (es)
CR (1)	CR8166A (es)
EA (1)	EA015491B1 (es)
EC (1)	ECSP056256A (es)
HK (1)	HK1097532A1 (es)
IL (1)	IL172713A0 (es)
NO (1)	NO333611B1 (es)
NZ (1)	NZ572901A (es)
TW (1)	TWI368510B (es)
UA (1)	UA86024C2 (es)
WO (1)	WO2005003131A1 (es)
ZA (1)	ZA200600770B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0300105D0 (sv) *	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) *	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
BRPI0411998A (pt)	2003-06-27	2006-09-05	Janssen Pharmaceutica Nv	moduladores delta-opióides tricìclicos
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7772271B2 (en)	2004-07-14	2010-08-10	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
KR20070083484A (ko)	2004-07-14	2007-08-24	피티씨 테라퓨틱스, 인크.	Ｃ형 간염 치료 방법
CN101022802A (zh)	2004-07-22	2007-08-22	Ptc医疗公司	用于治疗丙型肝炎的噻吩并吡啶化合物
EP1910353A1 (en) *	2004-08-05	2008-04-16	Janssen Pharmaceutica N.V.	Tricyclic delta- opioid modulators
US7589104B2 (en) *	2004-12-22	2009-09-15	Janssen Pharmaceutica Nv	Tricyclic-bridged piperidinyline derivatives as §-opioid modulators
EP1833826B1 (en) *	2004-12-22	2009-05-27	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
US20060135522A1 (en) *	2004-12-22	2006-06-22	Carson John R	Tricyclic delta-opioid modulators
JP2008526878A (ja) *	2005-01-06	2008-07-24	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	三環式δ−オピオイド調節剤
CA2611105A1 (en) *	2005-06-09	2006-12-21	Mallinckrodt Inc.	Method for separation and purification of naltrexone by preparative chromatography
DE602006018604D1 (de) *	2005-06-16	2011-01-13	Janssen Pharmaceutica Nv	Tricyclische opioidmodulatoren
CA2664345A1 (en)	2006-09-29	2008-04-03	Nippon Zoki Pharmaceutical Co., Ltd.	Oxepin derivative
US8715635B2 (en)	2007-02-06	2014-05-06	Technion Research & Development Foundation Limited	Frictionless molecular rotary motors
KR101379783B1 (ko)	2008-01-30	2014-03-31	니폰 조키 세야쿠 가부시키가이샤	피페리딘 유도체
CA2732282C (en) *	2008-08-01	2016-03-29	Nippon Zoki Pharmaceutical Co., Ltd.	Aminopropylidene derivative
IT1402691B1 (it) *	2010-11-10	2013-09-13	Lamberti Spa	Tioxantoni a bassa migrabilita'
JP7096817B2 (ja)	2016-11-04	2022-07-06	オークランドユニサービシーズリミティド	三環式複素環式誘導体及びその使用
WO2018119716A1 (en) *	2016-12-28	2018-07-05	Henkel Ag & Co. Kgaa	Thioxanthone derivative photoinitiator
CN110483871A (zh) *	2019-08-15	2019-11-22	陈全明	一种抗压耐磨的hdpe双壁波纹管

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2368006A (en) *	1943-10-07	1945-01-23	Searle & Co	Heterocyclic tertiary amines
FR1159125A (fr) *	1953-03-27	1958-06-23	Promonta Chem Fab	Procédé pour préparer des dérivés de la phényl-thiazine présentant comme substituant basique un noyau hétérocyclique contenant un atome d'azote
US2901478A (en) *	1957-02-11	1959-08-25	Promonta Chem Fab	Phenothiazine compounds
US3179665A (en) *	1959-12-16	1965-04-20	Wander Ag Dr A	9-(n-ethyl and n-propyl piperidyl-3'-methyl)-thioxanthenes
DE1159954B (de) *	1961-11-25	1963-12-27	Boehringer & Soehne Gmbh	Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
DE1670118A1 (de)	1966-07-22	1970-11-05	Boehringer Mannheim Gmbh	Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) *	1967-01-05	1969-09-30	Smithkline Corp	9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
NL6818027A (es) *	1968-01-09	1969-07-11
GB1250534A (es)	1969-03-03	1971-10-20
US3987042A (en) *	1969-03-03	1976-10-19	Claude Gueremy	Phenothiazine derivative
US3931232A (en) *	1974-06-24	1976-01-06	Smithkline Corporation	3-Alkyl xanthene compounds
ZA756550B (en) *	1974-11-06	1976-09-29	Smithkline Corp	Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
US4086350A (en) *	1974-11-06	1978-04-25	Smithkline Corporation	Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
US4285956A (en) *	1978-05-12	1981-08-25	Kefalas A/S	Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4356184A (en) *	1980-06-04	1982-10-26	G. D. Searle & Co.	Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4666907A (en) *	1983-10-05	1987-05-19	Merck Frosst Canada, Inc.	Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors
US4777177A (en) *	1984-10-19	1988-10-11	Ciba-Geigy Corporation	Pesticidal thioxanthen-9-ylidenepiperidines
FR2689013B1 (fr) *	1992-03-30	1995-05-05	Rhone Poulenc Rorer Sa	Nouvelle application thérapeutique des dérivés de la phénothiazine.
ZA978792B (en) *	1996-10-04	1998-04-06	Novo Nordisk As	N-substituted azaheterocyclic compounds.
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
AU7907298A (en) *	1997-06-25	1999-01-19	Novo Nordisk A/S	Novel heterocyclic compounds
US6040318A (en) *	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
ZA9811842B (en)	1997-12-24	2000-06-23	Ortho Mcneil Pharm Inc	4-[aryl(piperidin-4-yl)]aminobenzamides.
WO2001046191A1 (en)	1999-12-22	2001-06-28	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
JP2003525938A (ja) *	2000-03-03	2003-09-02	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	３−（ジアリールメチレン）−８−アザビシクロ［３．２．１］オクタン誘導体
AU2001249250A1 (en)	2000-03-29	2001-10-08	Research Triangle Institute	Selective ligands for the delta opioid receptor
SE0001207D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
EP1359146B1 (en)	2000-10-31	2008-04-09	Rensselaer Polytechnic Institute	4-aryl piperidines as opioid receptor binding agents
US6887876B2 (en)	2000-12-14	2005-05-03	Ortho-Mcneil Pharmaceutical, Inc.	Benzamidine derivatives
SE0101765D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
US6601009B2 (en) *	2001-07-12	2003-07-29	Yahoo Inc	Method and system of automatic bandwidth detection
WO2003018538A1 (fr) *	2001-08-31	2003-03-06	Ajinomoto Co., Inc.	Nouveaux derives de diarylalcene et nouveaux derives de diarylalcane
SE0103313D0 (sv) *	2001-10-03	2001-10-03	Astrazeneca Ab	Novel compounds
WO2003032912A2 (en) *	2001-10-16	2003-04-24	Hypnion, Inc.	Treatment of cns disorders using cns target modulators
EP1306376A1 (en)	2001-10-25	2003-05-02	Biofrontera Pharmaceuticals AG	Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
US7060711B2 (en) *	2001-10-25	2006-06-13	Biofrontera Bioscience Gmbh	Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1321169A1 (en)	2001-12-18	2003-06-25	Biofrontera Pharmaceuticals AG	Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
EP1538906A2 (en)	2002-09-18	2005-06-15	Fmc Corporation	Insecticidal tricyclic derivatives
US20040082612A1 (en)	2002-10-15	2004-04-29	Baxter Ellen W	Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives
MXPA05011163A (es)	2003-04-15	2005-12-14	Pfizer Prod Inc	Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides.
BRPI0411998A (pt)	2003-06-27	2006-09-05	Janssen Pharmaceutica Nv	moduladores delta-opióides tricìclicos
EP1910353A1 (en) *	2004-08-05	2008-04-16	Janssen Pharmaceutica N.V.	Tricyclic delta- opioid modulators
US7589104B2 (en) *	2004-12-22	2009-09-15	Janssen Pharmaceutica Nv	Tricyclic-bridged piperidinyline derivatives as §-opioid modulators
EP1833826B1 (en) *	2004-12-22	2009-05-27	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
US20060135522A1 (en) *	2004-12-22	2006-06-22	Carson John R	Tricyclic delta-opioid modulators
JP2008526878A (ja)	2005-01-06	2008-07-24	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	三環式δ−オピオイド調節剤
DE602006018604D1 (de) *	2005-06-16	2011-01-13	Janssen Pharmaceutica Nv	Tricyclische opioidmodulatoren

2004
- 2004-06-22 BR BRPI0411998-3A patent/BRPI0411998A/pt not_active IP Right Cessation
- 2004-06-22 AU AU2004253898A patent/AU2004253898A1/en not_active Abandoned
- 2004-06-22 US US10/873,527 patent/US7589103B2/en active Active
- 2004-06-22 CA CA2530444A patent/CA2530444C/en not_active Expired - Fee Related
- 2004-06-22 EA EA200501868A patent/EA015491B1/ru not_active IP Right Cessation
- 2004-06-22 EP EP04755822A patent/EP1644373A1/en not_active Withdrawn
- 2004-06-22 JP JP2006517517A patent/JP4810423B2/ja not_active Expired - Fee Related
- 2004-06-22 UA UAA200512736A patent/UA86024C2/ru unknown
- 2004-06-22 NZ NZ572901A patent/NZ572901A/en not_active IP Right Cessation
- 2004-06-22 KR KR1020057025145A patent/KR101132208B1/ko not_active Expired - Fee Related
- 2004-06-22 CN CNB2004800237098A patent/CN100513407C/zh not_active Expired - Fee Related
- 2004-06-22 WO PCT/US2004/019911 patent/WO2005003131A1/en active Application Filing
- 2004-06-28 AR ARP040102271A patent/AR044940A1/es not_active Application Discontinuation
- 2004-06-28 TW TW093118831A patent/TWI368510B/zh not_active IP Right Cessation
2005
- 2005-12-20 IL IL172713A patent/IL172713A0/en unknown
- 2005-12-27 EC EC2005006256A patent/ECSP056256A/es unknown
2006
- 2006-01-02 CR CR8166A patent/CR8166A/es not_active Application Discontinuation
- 2006-01-26 ZA ZA200600770A patent/ZA200600770B/en unknown
- 2006-01-27 NO NO20060446A patent/NO333611B1/no not_active IP Right Cessation
2007
- 2007-03-23 HK HK07103171.8A patent/HK1097532A1/xx not_active IP Right Cessation
2009
- 2009-08-06 US US12/536,635 patent/US7982042B2/en not_active Expired - Fee Related
2011
- 2011-06-10 US US13/157,846 patent/US8106207B2/en not_active Expired - Fee Related
- 2011-12-22 US US13/334,374 patent/US8350041B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1839135A (zh)	2006-09-27
WO2005003131A1 (en)	2005-01-13
EA200501868A1 (ru)	2006-06-30
EA015491B1 (ru)	2011-08-30
ECSP056256A (es)	2006-04-19
JP4810423B2 (ja)	2011-11-09
NZ572901A (en)	2010-06-25
KR20060035645A (ko)	2006-04-26
BRPI0411998A (pt)	2006-09-05
IL172713A0 (en)	2006-04-10
NO20060446L (no)	2006-03-27
ZA200600770B (en)	2007-05-30
US20110245291A1 (en)	2011-10-06
US20120095010A1 (en)	2012-04-19
CR8166A (es)	2009-01-16
KR101132208B1 (ko)	2012-04-12
UA86024C2 (ru)	2009-03-25
US8106207B2 (en)	2012-01-31
EP1644373A1 (en)	2006-04-12
US7589103B2 (en)	2009-09-15
NO333611B1 (no)	2013-07-22
US20090298867A1 (en)	2009-12-03
CA2530444C (en)	2012-03-13
US7982042B2 (en)	2011-07-19
US8350041B2 (en)	2013-01-08
AU2004253898A1 (en)	2005-01-13
CN100513407C (zh)	2009-07-15
AR044940A1 (es)	2005-10-12
TWI368510B (en)	2012-07-21
US20050009860A1 (en)	2005-01-13
JP2007516175A (ja)	2007-06-21
CA2530444A1 (en)	2005-01-13
TW200528105A (en)	2005-09-01

Publication	Publication Date	Title
HK1097532A1 (en)	2007-06-29	Tricyclic delta opioid modulators
GB2401643B (en)	2006-06-07	Padlock
AU158373S (en)	2005-11-14	Set of containers
GB0305010D0 (en)	2003-04-09	Changing colours
EP1701869A4 (en)	2008-03-26	inflation
HK1074622A1 (en)	2005-11-18	Tricyclic spiropiperidines or spiropyrolidines
EP1632492A4 (en)	2010-08-25	TRICYCLIC CONNECTION
GB0329314D0 (en)	2004-01-21	Substituted arylpyrazoles
IL181120A0 (en)	2008-03-20	Tricyclic ?? -opioid modulators
GB0324428D0 (en)	2003-11-19	Modulator
GB0306575D0 (en)	2003-04-30	Modulators
HK1105634A1 (en)	2008-02-22	Heteroatoms-containing tricyclic compounds
IL166668A0 (en)	2006-01-15	Patches containing turobuterol
GB2409252B (en)	2007-03-21	Anti-theft device
GB2406494B (en)	2006-11-15	Anti-theft device
AU154202S (en)	2004-01-02	Tire
GB0302407D0 (en)	2003-03-05	Tire
AU2906P (en)	2005-10-18	DBB03 Dianella caerulea
AU2907P (en)	2005-10-18	DCMP01 Dianella caerulea
AU2908P (en)	2005-10-18	DCNCO Dianella caerulea
GB2399126B (en)	2006-01-25	Shackle
GB0304067D0 (en)	2003-03-26	Substances
GB0311397D0 (en)	2003-06-25	Substances
GB0304999D0 (en)	2003-04-09	Substances
GB0301814D0 (en)	2003-02-26	Substances

Legal Events

Date	Code	Title	Description
2017-01-20	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20160622